Company Overview

Update
Founded:
2007
Founders:
David R. Walt
Headquarters:
Cambridge, MA
Funding:
$44M
Categories:
Analytics, Biotechnology
Description:
Quanterix is a platform for single molecule analysis that supports clinical diagnostics, drug development, and life science researches.

Detailed Description

Update

Quanterix Corporation is developing a novel platform for single molecule analysis that will bring an unprecedented level of sensitivity, precision, and assay robustness to clinical diagnostics, drug development, and life science research. Their unique approach permits rapid quantification and analysis of individual proteins and small molecules within complex biological samples, enabling us to address a variety of unmet medical needs. Founded in 2007, Quanterix is backed by leading life science investors including ARCH Venture Partners, Bain Capital Ventures, and Flagship Ventures.

Current Team (8)

Update

Funding Rounds (5) - $44M

Update

Board Members and Advisors (6)

Update

Investors (4)

Update
  • 920ef1c9e2d2a1b871893ee51107f97c

    ARCH Venture Partners

    ARCH invests primarily in companies co-founded with leading scientists and entrepreneurs,...
  • 179e6f8b3e38a786db31104370625ec8

    Flagship Ventures

    Realizing entrepreneurial innovation is the mission of Flagship Ventures. The firm operates...
  • 2728ac372a946528e6ad76c8e0ee4851

    Bain Capital Ventures

    Venture capital firm
  • Ce1e594e7b3e9c430035a017b0d8393b

    In-Q-Tel

    In-Q-Tel identifies and partners with companies developing cutting-edge technologies to help...

Offices/Locations (1)

Update
  • Office

    One Kendall Square

    Building 1400

    Cambridge, MA 02139

    USA